Brand New Galaxy Launches Western European Operation in Amsterdam
17.2.2021 09:00:00 EET | Business Wire | Press release
The rapidly growing global marketing and technology company, Brand New Galaxy launches their Western European Operation in Amsterdam, The Netherlands. The group’s mission is to provide highly specialized and data optimized solutions in E-commerce, Creative & Content Production, and Automation & Performance Improvement from the Dutch capital. Award-winning global marketing and advertising leader, Frank Carvalho is driving the growth of the new operation as Managing Director.
“Our mission is growth. We are growing rapidly, because we are built to drive performance via highly specialized and data optimized solutions for our clients. We deliver growth by utilizing our unique digital offerings and our global network of companies specialized in E-commerce, Creative & Content Production, and Automation & Performance Improvement. We set up our new office in Amsterdam, because the Dutch capital is growing too, becoming the new commercial hub of Europe,” says Frank Carvalho, Managing Director, Brand New Galaxy Amsterdam.
The award-winning Brand New Galaxy is a global provider of end-to-end E-commerce solutions and content production. The company offers several unique methodologies, including Robonauts Pictures E-commerce Real Feel, using production twists that makes online consumers’ product experience comparable to a physical one. Another specialized solution is their FMCC - Fast Moving Consumer Communications method that delivers a quick and scalable content production solution. Part of Brand New Galaxy’s proprietary tools is Synthrone, a modular and flexible ecosystem of automated services for content storage, creation, localization, publishing, tracking, and reporting.
“Efficient management of the entire digital ecosystem is a priority for all businesses who are looking for ways to drive their solid growth in E-commerce. Therefore, as an end-to-end E-commerce player founded on global-to-local methodology we see closer cooperation with our customers in Western Europe as a must have. Our Amsterdam office is a natural consequence of building convenient hubs for well-developed clients and those who are at the early stage of their E-commerce journey,” says Michał Glapiński, Chief Growth Officer responsible for international operations of Brand New Galaxy.
Galactic Growth
Brand New Galaxy has been growing rapidly in the last couple of years by opening new offices and acquiring new companies. Just in 2020 the group launched three offices on three continents, including the United States, the Middle East and Europe. Last year their workforce increased by almost 35 percent to more than 500 employees, with 80 percent of the professionals are working on global and regional levels. They supply global and local services to over 200 clients in 29 languages, from Fortune 500 companies to E-commerce players from small-to-medium-sized businesses. Brand New Galaxy is a three-time winner of the prestigious Press Magazine Awards.
Galactic Talent
Brand New Galaxy’s new Western European operation has a truly global leader. Frank Carvalho, Managing Director has more than 25 years of experience in marketing and advertising from all over the World, including the United States, the United Kingdom, Germany, Poland, Hungary and Australia. He is moving to Amsterdam from New York City, where he was the leader of Account Management in North America and a Global Businesses Director at Hogarth, part of WPP. Some other highlights of his multi-decade career include spending 15 years with the Publicis Groupe as Regional Client Services Director and European Business Lead on Samsung; and being the Senior Brand and Marketing Director at Vodafone in Czech Republic. He has extensive experience in the financial, professional services, pharmaceutical, tobacco, automotive, telecommunications and media sector. He is the winner of four Cannes Lions Awards.
About Brand New Galaxy
Brand New Galaxy is a fast-growing, independent holding of marketing and technology agencies. The privately-owned “independent marketing platform” was founded in Warsaw, Poland in 2017 and has grown to 500+ employees to date. Brand New Galaxy invests in innovative and dynamic ideas that thrive in a start-up environment and are scalable to compete with network agencies. Brand New Galaxy is a member of the MDC Global Affiliates program. Named “Debut of the Year 2018”, “Success of the Year 2019”, “Success of the Year 2020” BNG scores first places in a prestigious agency ranking by PRESS magazine.
Brand New Galaxy companies include:
Pathfinder 23 – global E-commerce agency; Life on Mars – beauty & fashion production agency; Spacecamp – global digital agency; Synthrone - E-commerce automation and implementation platform; Voyager - E-business delivery agency; New Gravity - software & direct-to- consumer house; Robonauts Pictures - E-commerce production house; content26 - Amazon content & advertising, Man on the Moon - HR Agency; BNG MEA – Dubai based hub driving commerce in MEA region; Brand New Galaxy AMS – Amsterdam based hub igniting growth for businesses in Western Europe.
More information:
Web: ams.brandnewgalaxy.com
Downloads: BNG AMS MEDIA
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210216006090/en/
Contact information
Jagoda Prętnicka
Head of Communications
Brand New Galaxy
(+48) 506 780 846
j.pretnicka@brandnewgalaxy.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom